Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrahypofractionation of localized prostate cancer-an updated statement of the prostate cancer working group of the German Society of Radiation Oncology (DEGRO).

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Same author

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors.

ESMO open·2026
Same author

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Biomarkers in prostate cancer: current status and future directions in radiotherapy-statement from the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO).

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2025
Same author

Validation of patient-specific deep learning markerless lung tumor tracking aided by 4DCBCT.

Physics in medicine and biology·2025
Same author

Radio(chemo)therapy in anal cancer: evaluation of sex-specific disparities across AJCC stages.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2025

Related Experiment Video

Updated: Jul 3, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

[Radiotherapy in prostate cancer].

U Ganswindt1, C Belka

  • 1Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Ludwig-Maximilians-Universität München, München, Deutschland. ute.ganswindt@med.uni-muenchen.de

Der Urologe. Ausg. A
|July 22, 2008
PubMed
Summary

Radiotherapy is an effective treatment for localized prostate cancer, comparable to surgery when delivered at sufficient doses. Advances like intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT) enhance efficacy and reduce side effects.

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Experiment Videos

Last Updated: Jul 3, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Area of Science:

  • Oncology
  • Radiation Oncology

Context:

  • Prostate cancer treatment landscape.
  • Established role of radiotherapy.

Purpose:

  • To review the efficacy and advancements in radiotherapy for localized prostate cancer.
  • To highlight the benefits of modern radiotherapy techniques and combination therapies.

Summary:

  • Radiotherapy, including interstitial brachytherapy and external beam radiotherapy, is a well-accepted and effective treatment for localized prostate cancer, offering comparable outcomes to radical prostatectomy when sufficient doses are administered.
  • Advancements such as intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT) enable higher radiation doses with reduced toxicity.
  • Combining radiotherapy with hormonal ablation improves local control in specific patient groups, while adjuvant or salvage radiotherapy plays a crucial role after surgery or in cases of relapse.

Impact:

  • Enhanced radiotherapy techniques improve treatment outcomes and patient quality of life.
  • Radiotherapy remains a vital curative and adjuvant treatment option for prostate cancer.
  • Further research into IGRT and IMRT integration promises even better results.